We are live on ! Find out more
NRC icon

NRC Health Common Stock

94 hedge funds and large institutions have $462M invested in NRC Health Common Stock in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 32 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 11

3% more funds holding

Funds holding: 9194 (+3)

0.95% more ownership

Funds ownership: 41.73%42.67% (+0.95%)

6% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 32

11% less capital invested

Capital invested by funds: $519M → $462M (-$56.6M)

Holders
94
Holders Change
+3
Holders Change %
+3.3%
% of All Funds
1.66%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
30
Reduced
32
Closed
11
Calls
Puts
Net Calls
Net Calls Change

NRC Hedge Fund Activity: Q4 2020 in Review

94 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in NRC Health Common Stock (NRC) for Q4 2020, worth a combined $462M — down 11% from $519M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new NRC positions and 11 closed out — a net gain of 3 holders — while 30 added to existing stakes and 32 trimmed.

The largest buyer was Royal Bank of Canada, adding an estimated $7.2M. The largest seller was Royce & Associates, cutting an estimated $2.73M.

  • 94 institutional investors held NRC Health Common Stock (NRC) as of Q4 2020, up from 91 in Q3 2020.
  • Funds reported $462M of NRC Health Common Stock stock for Q4 2020, down 11% quarter-over-quarter.
  • 14 funds opened new NRC Health Common Stock positions in Q4 2020 and 11 closed out, a net change of +3 holders.
  • The largest NRC Health Common Stock buyer in Q4 2020 was Royal Bank of Canada, an estimated $7.2M added.
  • The largest NRC Health Common Stock seller in Q4 2020 was Royce & Associates, an estimated $2.73M sold.

Based on aggregated 13F filings for Q4 2020.